Live Breaking News & Updates on Xianquan Zhan

Stay updated with breaking news from Xianquan zhan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Latest Articles

Latest Articles
freerepublic.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freerepublic.com Daily Mail and Mail on Sunday newspapers.

United States , White House , District Of Columbia , New York , South China Sea , Brunei General , Leonid Ivashov , Jack Newman , Bishopr Barron , Michael Brown , Joe Biden , David Zukerman , Liz Cheney , Rachel Alexander , Justin Trudeau , Jim Robinson , Carl Vinson , Jonathan Feldstein , Joe Rogan , Vladimir Putin , Dwayne Johnson , George Orwell , Li Xianquan Zhan , Jon Mitchell , Jack Furnari , Kelly Egan ,

Latest Articles

Latest Articles
freerepublic.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freerepublic.com Daily Mail and Mail on Sunday newspapers.

New York , United States , South Carolina , West Point , White House , District Of Columbia , Capitol Hill , Erie County , Thomas Binger , Molly Sharlach , Alexandra Ellerbeck , Xianquan Zhan , Maxine Joselow , Anthony Fauci , Vasko Kohlmayer , Tom Golisano , Dave Hancock , Maki Becker , Tony Fauci , Kerry George , Andrew Cuomo , Jack Posobiec , Nikki Haley , Rand Paul , Gabriella Hoffman , Kyle Rittenhouse ,

Mountain Valley MD Proceeding With Pre-Clinical Cancer Trials, Files Related Cancer Patent


Share this article
Share this article
TORONTO, May 3, 2021 /PRNewswire/ -
 Mountain Valley MD Holdings Inc. (the
Company or
MVMD ) (CSE: MVMD) (FRA: 20MP) (OTCQB: MVMDF) is pleased to announce that the Company has filed a novel cancer adjuvant patent and is proceeding with pre-clinical trials with third-party cancer Contract Research Organizations (CROs) in triple-negative breast cancer, metastatic melanoma, and lung carcinoma.
Summary
MVMD files cancer patent for direct intratumoral injection, intravenously, infusions or instillations as adjuvants for broad chemotherapeutic to immunotherapeutic cancer regimens.
The Company is proceeding with three separate pre-clinical trials with specialized third-party cancer CROs: (1) triple-negative breast cancer; (2) metastatic melanoma; and (3) Lewis Lung Carcinoma as a proxy for non-small cell lung carcinoma. ....

Xianquan Zhan , Zhijun Zhao , Liang Chen , Castro Jr , Fernanda Saldivar , Julia Aguade Gorgorio , Caterina Mezzatesta , Mingyang Tang , Chen Ying Yu , Mike Farber , Guadalupe Dominguez , Jose Luis Medina , Martin Stanulla , Blerim Marovca , Silvia Jenni , Qiuren Wei , Anna Guinot , Jana Burger , Qiang Fang , Jiangyan Li , Xin Yao , Martin Schrappe , Zhen Han , Fuying Cheng , Liridon Abduli , Darrellj Irvine ,